vs
ALPHA & OMEGA SEMICONDUCTOR Ltd（AOSL）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
ALPHA & OMEGA SEMICONDUCTOR Ltd的季度营收约是再鼎医药的1.3倍（$162.3M vs $127.1M），再鼎医药同比增速更快（17.1% vs -6.3%），ALPHA & OMEGA SEMICONDUCTOR Ltd自由现金流更多（$-23.1M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 4.0%）
Alpha & Omega Semiconductor是一家专业功率半导体供应商，主营功率MOSFET、IGBT、模拟芯片及电源管理模块的研发、生产与销售，产品广泛应用于消费电子、工业设备、汽车、通信和计算等领域，业务覆盖全球主要市场。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
AOSL vs ZLAB — 直观对比
营收规模更大
AOSL
是对方的1.3倍
$127.1M
营收增速更快
ZLAB
高出23.4%
-6.3%
自由现金流更多
AOSL
多$3.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
4.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $162.3M | $127.1M |
| 净利润 | $-13.3M | — |
| 毛利率 | 21.5% | 51.0% |
| 营业利润率 | -8.4% | -54.6% |
| 净利率 | -8.2% | — |
| 营收同比 | -6.3% | 17.1% |
| 净利润同比 | -101.0% | — |
| 每股收益（稀释后） | $-0.45 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AOSLZLAB
| Q4 25 | $162.3M | $127.1M | ||
| Q3 25 | $182.5M | $115.4M | ||
| Q2 25 | $176.5M | $109.1M | ||
| Q1 25 | $164.6M | $105.7M | ||
| Q4 24 | $173.2M | $108.5M | ||
| Q3 24 | $181.9M | $101.8M | ||
| Q2 24 | $161.3M | $100.1M | ||
| Q1 24 | $150.1M | $87.1M |
净利润AOSLZLAB
| Q4 25 | $-13.3M | — | ||
| Q3 25 | $-2.1M | $-36.0M | ||
| Q2 25 | $-77.1M | $-40.7M | ||
| Q1 25 | $-10.8M | $-48.4M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-2.5M | $-41.7M | ||
| Q2 24 | $-2.7M | $-80.3M | ||
| Q1 24 | $-11.2M | $-53.5M |
毛利率AOSLZLAB
| Q4 25 | 21.5% | 51.0% | ||
| Q3 25 | 23.5% | 59.5% | ||
| Q2 25 | 23.4% | 60.6% | ||
| Q1 25 | 21.4% | 63.6% | ||
| Q4 24 | 23.1% | 61.5% | ||
| Q3 24 | 24.5% | 64.1% | ||
| Q2 24 | 25.7% | 64.9% | ||
| Q1 24 | 23.7% | 61.4% |
营业利润率AOSLZLAB
| Q4 25 | -8.4% | -54.6% | ||
| Q3 25 | -2.5% | -42.3% | ||
| Q2 25 | -6.6% | -50.3% | ||
| Q1 25 | -6.5% | -53.3% | ||
| Q4 24 | -3.4% | -62.6% | ||
| Q3 24 | -0.1% | -66.6% | ||
| Q2 24 | -0.9% | -76.0% | ||
| Q1 24 | -7.0% | -80.7% |
净利率AOSLZLAB
| Q4 25 | -8.2% | — | ||
| Q3 25 | -1.2% | -31.2% | ||
| Q2 25 | -43.7% | -37.3% | ||
| Q1 25 | -6.6% | -45.8% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -1.4% | -40.9% | ||
| Q2 24 | -1.7% | -80.2% | ||
| Q1 24 | -7.5% | -61.4% |
每股收益（稀释后）AOSLZLAB
| Q4 25 | $-0.45 | $-0.05 | ||
| Q3 25 | $-0.07 | $-0.03 | ||
| Q2 25 | $-2.61 | $-0.04 | ||
| Q1 25 | $-0.37 | $-0.04 | ||
| Q4 24 | $-0.23 | $-0.09 | ||
| Q3 24 | $-0.09 | $-0.04 | ||
| Q2 24 | $-0.09 | $-0.08 | ||
| Q1 24 | $-0.39 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.3M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $818.8M | $715.5M |
| 总资产 | $1.0B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AOSLZLAB
| Q4 25 | $196.3M | $689.6M | ||
| Q3 25 | $223.5M | $717.2M | ||
| Q2 25 | $153.1M | $732.2M | ||
| Q1 25 | $169.4M | $757.3M | ||
| Q4 24 | $182.6M | $779.7M | ||
| Q3 24 | $176.0M | $616.1M | ||
| Q2 24 | $175.1M | $630.0M | ||
| Q1 24 | $174.4M | $650.8M |
总债务AOSLZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $14.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $26.7M | — | ||
| Q1 24 | — | — |
股东权益AOSLZLAB
| Q4 25 | $818.8M | $715.5M | ||
| Q3 25 | $834.1M | $759.9M | ||
| Q2 25 | $822.3M | $791.7M | ||
| Q1 25 | $886.3M | $810.8M | ||
| Q4 24 | $902.6M | $840.9M | ||
| Q3 24 | $895.3M | $667.7M | ||
| Q2 24 | $891.6M | $704.2M | ||
| Q1 24 | $888.9M | $762.2M |
总资产AOSLZLAB
| Q4 25 | $1.0B | $1.2B | ||
| Q3 25 | $1.0B | $1.2B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.1B | $985.3M | ||
| Q2 24 | $1.1B | $987.4M | ||
| Q1 24 | $1.2B | $988.4M |
负债/权益比AOSLZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.03× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-26.7M |
| 自由现金流率自由现金流/营收 | -14.2% | -21.0% |
| 资本支出强度资本支出/营收 | 9.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.9M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流AOSLZLAB
| Q4 25 | $-8.1M | $-26.0M | ||
| Q3 25 | $10.2M | $-32.0M | ||
| Q2 25 | $-2.8M | $-31.0M | ||
| Q1 25 | $7.4M | $-61.7M | ||
| Q4 24 | $14.1M | $-55.8M | ||
| Q3 24 | $11.0M | $-26.8M | ||
| Q2 24 | $7.1M | $-42.2M | ||
| Q1 24 | $28.2M | $-90.1M |
自由现金流AOSLZLAB
| Q4 25 | $-23.1M | $-26.7M | ||
| Q3 25 | $420.0K | $-35.0M | ||
| Q2 25 | $-17.2M | $-33.9M | ||
| Q1 25 | $-1.1M | $-63.2M | ||
| Q4 24 | $6.6M | $-58.4M | ||
| Q3 24 | $4.1M | $-28.2M | ||
| Q2 24 | $-210.0K | $-42.9M | ||
| Q1 24 | $20.5M | $-91.1M |
自由现金流率AOSLZLAB
| Q4 25 | -14.2% | -21.0% | ||
| Q3 25 | 0.2% | -30.4% | ||
| Q2 25 | -9.7% | -31.1% | ||
| Q1 25 | -0.6% | -59.9% | ||
| Q4 24 | 3.8% | -53.8% | ||
| Q3 24 | 2.3% | -27.7% | ||
| Q2 24 | -0.1% | -42.9% | ||
| Q1 24 | 13.7% | -104.5% |
资本支出强度AOSLZLAB
| Q4 25 | 9.2% | 0.5% | ||
| Q3 25 | 5.4% | 2.6% | ||
| Q2 25 | 8.1% | 2.6% | ||
| Q1 25 | 5.1% | 1.5% | ||
| Q4 24 | 4.3% | 2.4% | ||
| Q3 24 | 3.8% | 1.3% | ||
| Q2 24 | 4.5% | 0.7% | ||
| Q1 24 | 5.2% | 1.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AOSL
| Power Discrete | $101.0M | 62% |
| Power Ic | $58.8M | 36% |
| Packaging And Testing Services | $2.5M | 2% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
